Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRTX vs MRNA✓SelectedUSD · MRNAVRTX vs MRNA performance historyLatest closeAs of-0.15%11/16
Stock and ETF performance explorer

VRTX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+23.2%
MRNA return
+330.7%
Excess return
-307.5%
Maximum drawdown
-13.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.2%-3.6%+3.5%0.0%
7D-2.4%-20.0%+17.6%-1.6%
30D+7.6%-1.3%+8.9%+7.5%
3M+6.3%+240.0%-233.6%0.0%
All+23.2%+330.7%-307.5%+12.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling